Active substance (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Technical information
Presentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
aMNNL46vJ5Y6HBXY
Listen
